Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This syndrome is characterized by sclerosing bone dysplasia, ichthyosis vulgaris and premature ovarian failure. The bone disorder affects all metaphyseal-diaphyseal regions of the long bones, the skull, and the metacarpals.
Features include always present findings: Hypoplasia of the ovary; and common findings: Premature ovarian insufficiency. 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 2 | Subperiosteal bone formation, Osteosclerosis of the base of the skull |
Biomarker and diagnostic research for osteosclerosis-ichthyosis-premature ovarian failure syndrome has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for osteosclerosis-ichthyosis-premature ovarian failure syndrome.
187 publications have been identified in PubMed for osteosclerosis-ichthyosis-premature ovarian failure syndrome. Kisho has analyzed 133 by research type. Research spans Review / Meta-Analysis (56%), Case Report / Case Series (14%), and Basic Science / Preclinical (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 74 | 56% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 5:34 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Dry, scaly skin (ichthyosis) |
Arms and legs | 1 | Lower limb pain |
Patient case studies |
19 |
14% |
Laboratory research | 15 | 11% |
Disease patterns and progression | 15 | 11% |
Testing and diagnosis research | 5 | 4% |
Clinical study results | 3 | 2% |
New treatment approaches | 2 | 2% |
Douglas JA (2026). [PMID: 41897319](https://pubmed.ncbi.nlm.nih.gov/41897319/). *Biomolecules*. [Review / Meta-Analysis]
Chen X (2026). [PMID: 41033872](https://pubmed.ncbi.nlm.nih.gov/41033872/). *Trends Mol Med*. [Review / Meta-Analysis]
Chen Y (2026). [PMID: 41699950](https://pubmed.ncbi.nlm.nih.gov/41699950/). *Basic Clin Pharmacol Toxicol*. [Review / Meta-Analysis]
Mao R (2026). [PMID: 41406609](https://pubmed.ncbi.nlm.nih.gov/41406609/). *J Trace Elem Med Biol*. [Review / Meta-Analysis]
Fathi B (2026). [PMID: 42057055](https://pubmed.ncbi.nlm.nih.gov/42057055/). *BMC Womens Health*. [Basic Science / Preclinical]
Savas M (2026). [PMID: 42208956](https://pubmed.ncbi.nlm.nih.gov/42208956/). *Lancet Diabetes Endocrinol*. [Review / Meta-Analysis]
Matheou M (2026). [PMID: 41163431](https://pubmed.ncbi.nlm.nih.gov/41163431/). *Clin Genet*. [Case Report / Case Series]
Wang Z (2026). [PMID: 40921996](https://pubmed.ncbi.nlm.nih.gov/40921996/). *Biol Trace Elem Res*. [Review / Meta-Analysis]
Gu H (2026). [PMID: 41270827](https://pubmed.ncbi.nlm.nih.gov/41270827/). *J Genet Genomics*. [Review / Meta-Analysis]
Fu Q (2026). [PMID: 40982365](https://pubmed.ncbi.nlm.nih.gov/40982365/). *Physiology (Bethesda)*. [Review / Meta-Analysis]